Physician profile
Inder M Singh
NPI 1447456736
$6,122.40
in general payments reported to CMS, 2019-2025
21 companies · $479 in 2025
The $479 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $233 · 2020: $60.71 · 2021: $4,542 · 2022: $114 · 2023: $226 · 2024: $467 · 2025: $479.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,172.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,172.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acist Medical Systems, INC. | $4,000.00 | 2021 | |
| Boston Scientific Corporation | $681.33 | 2019-2025 | Resolution 360 Clip, Overstitch Endoscopic Suturing System |
| Bard Peripheral Vascular, INC. | $424.90 | 2024 | Lutonix Drug Coated Balloon |
| Reflow Medical INC | $151.48 | 2025 | |
| Abbvie INC. | $149.96 | 2019-2025 | |
| Abbott Laboratories | $137.92 | 2023 | Diamondback Peripheral |
| Livanova USA, INC. | $122.00 | 2021 | |
| Janssen Biotech, INC. | $98.14 | 2021-2022 | |
| Medtronic, INC. | $74.31 | 2023 | Reveal Linq |
| Qol Medical, LLC | $34.04 | 2019 | |
| Braintree Laboratories, INC. | $33.23 | 2019 | |
| Cardiovascular Systems INC. | $32.73 | 2022-2023 | Diamondback Peripheral |
| Philips North America LLC | $28.99 | 2025 | Mcot |
| Angiodynamics, INC. | $27.15 | 2022 | |
| Shockwave Medical, INC | $23.85 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $23.75 | 2019 | |
| Organogenesis INC. | $21.17 | 2024 | Nushield |
| Merck Sharp & Dohme LLC | $20.90 | 2024 | Verquvo |
| Takeda Pharmaceuticals U.S.A., INC. | $14.92 | 2019 | |
| Daiichi Sankyo INC. | $12.24 | 2019 | |
| Romark Laboratories, Lc | $9.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Inder Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.